- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00735657
Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle
November 21, 2021 updated by: King Khaled Eye Specialist Hospital
Anesthesia for PPV Using Insulin Needle
Periocular blockade with 12.5 mm needle is as effective as block with 25 mm needle for patients undergoing Pars Plana Vitrectomy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The author wants to see the effect of short needle in patients undergoing retinal surgery.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Riyadh, Saudi Arabia, 11462
- King Khaled Eye Specialist Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patients undergoing pars plana vitrectomy under local anesthesia
Exclusion Criteria:
- Patients allergic to local anesthetic solutions
- With local sepsis
- Serious impairment of coagulation
- Orbital abnormalities
- Unable to cooperate in maintaining a relatively motionless supine position
- Who refused the anesthetic technique
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Group 1
Control
|
Peribulbar blockade with standard (25 mm) needle
Other Names:
Peribulbar blockade with short (12.5 mm) needle
Other Names:
Peribulbar block
Other Names:
|
ACTIVE_COMPARATOR: Group 2
Block with short needle
|
Peribulbar blockade with standard (25 mm) needle
Other Names:
Peribulbar blockade with short (12.5 mm) needle
Other Names:
Peribulbar block
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Efficacy of insulin needle.
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Waleed Riad, MD, KKESH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (ACTUAL)
August 1, 2009
Study Completion (ACTUAL)
December 1, 2010
Study Registration Dates
First Submitted
July 1, 2008
First Submitted That Met QC Criteria
August 14, 2008
First Posted (ESTIMATE)
August 15, 2008
Study Record Updates
Last Update Posted (ACTUAL)
December 2, 2021
Last Update Submitted That Met QC Criteria
November 21, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rp0822
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Disorders
-
San Ni ChenCompletedSurgery | Retinal Detachment
-
Shahid Beheshti University of Medical SciencesUnknownPseudophakic Retinal Detachment | Aphakic Retinal DetachmentIran, Islamic Republic of
-
Kyorin UniversityCompletedMacular Hole Retinal Detachment
-
Nantes University HospitalCompletedRetinal Diseases | AmaurosisFrance
-
Unity Health TorontoRecruitingRhegmatogenous Retinal DetachmentCanada
-
Sunnybrook Health Sciences CentreRecruitingRhegmatogenous Retinal DetachmentCanada
-
Francine Behar-CohenEmory University; University of Lausanne HospitalsCompletedRhegmatogenous Retinal DetachmentSwitzerland
-
Centre Hospitalier Universitaire DijonNot yet recruitingRhegmatogenous Retinal DetachmentsFrance
-
Medical University of ViennaRecruiting
-
Unity Health TorontoCompletedRhegmatogenous Retinal DetachmentCanada
Clinical Trials on needle
-
Guang'anmen Hospital of China Academy of Chinese...Completed
-
University of California, San FranciscoBaylis Medical CompanyCompletedHeart DiseasesUnited States
-
Postgraduate Institute of Medical Education and...CompletedUpper Extremity Injury Trauma
-
Istituto Clinico HumanitasUnknownPancreatic Cancer | Neuroendocrine Tumors | GIST | Lymphadenopathies | Gastric Wall TumorItaly
-
Boston Scientific CorporationCompletedPancreatic Cystic LesionsUnited States, China, India
-
Philips HealthcareWithdrawnProstate CancerUnited States
-
Kyungpook National University HospitalRecruitingAnalgesia, EpiduralKorea, Republic of
-
Kyungpook National University HospitalCompletedDisk Herniated Lumbar | Spinal Stenosis LumbarKorea, Republic of
-
The University of Hong KongUnknown
-
University of ChicagoCook Group IncorporatedCompletedPancreatic CancerUnited States